Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Time for action regarding cardiovascular emergency care at sports arenas: a lesson from the arena study
On behalf of the Sports Cardiology Section of the European Association of Cardiovascular Prevention and Rehabilitation, doi:10.1093/eurheartj/ehq006.
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol - Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005;26:516-24.
Recommendations for competitive sports participation in athletes with cardiovascular disease. A consensus document from the Study group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005;26:1422-45.
Consensus document regarding cardiovascular safety at sports arenas
Position stand from the European Association of Cardiovascular Prevention and Rehabilitation (EACPR), section of Sports Cardiology
Eur Heart J (2011) doi:10.1093/eurheartj/ehr178
ESC Study Group of Sports Cardiology: recommendations for participation in leisure-time physical activity and competitive sports for patients with ischaemic heart disease
EJCPR. 13(2):137-149, April 2006.
ESC Study Group of Sports Cardiology Position Paper on adverse cardiovascular effects of doping in athletes
EJCPR. 13(5):687-694, October 2006.
Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers
on behalf of the Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention and Rehabilitation
EJCPR August 2006; vol. 13, 4: pp. 475-484
Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions Part II: Ventricular arrhythmias, channelopathies and implantable defibrillators
On behalf of the Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention and Rehabilitation
EJCPR October 2006; vol. 13, 5: pp. 676-686
ESC Study Group of Sports Cardiology Recommendations for participation in leisure-time physical activities and competitive sports for patients with hypertension
EJCPR. 12(4):326-331, August 2005.
Other publications selected by the EACPR Sports Cardiology Section
Erik Ekker Solberg, Bernt Inge Embrå, Mats Börjesson, Johan Herlitz, Domenico Corrado
European Journal of Preventive Cardiology June 2011 vol. 18 no. 3 378-383
E E Solberg, T H Bjørnstad, T E Andersen, and Ø Ekeberg
European Journal of Cardiovascular Prevention & Rehabilitation, 1741826711410818, first published on May 25, 2011
Erik Ekker Solberg, Finn Gjertsen, Erlend Haugstad and Lars Kolsrud
The implementation of 12-lead ECG in the pre-participation screening of young athletes is still controversial and numbers of issues are largely debated, including the prevalence and spectrum of ECG abnormalities found in individuals undergoing pre-participation screening. METHODS AND RESULTS: We assessed a large, unselected population of 32,652 subjects [26 050 (80%) males], prospectively examined in 19 clinics associated to Italian Sports Medicine Federation. Most were young amateur athletes, aged 8-78 years (median 17). The prevalence of markedly abnormal ECG patterns, suggestive for structural cardiac disease, is low (<5% of the overall population) and should not represent obstacle for implementation of 12-lead ECG in the pre-participation screening program.
Outcomes in athletes with marked ECG repolarization abnormalities.
Pelliccia A, Di Paolo FM, Quattrini FM, Basso C, Culasso F, Popoli G, De Luca R, Spataro A, Biffi A, Thiene G, Maron BJ.
Some athletes can manifest trivial abnormalities of 12 leads ECG without evidence of structural heart disease and are a difficult diagnostic problem because the natural history of these subjects it is still unknown. This article concerns a large series of top level athletes with long term follow up and demonstrates that markedly abnormal ECGs in young and apparently healthy athletes may represent the initial expression of underlying cardiomyopathies that may not be evident until many years later and that may ultimately be associated with adverse outcomes. Athletes with such ECG patterns merit continued clinical surveillance. Athletes with normal ECG during the inclusion did not manifest, during a long term follow up, any problem This article reinforces the usefulness of 12 leads ECG during athletes screening both in subjects with normal and in those with abnormal 12 leads ECG.
© 2017 European Society of Cardiology. All rights reserved